Stockreport

AN2 Therapeutics raises $40M privately [Seeking Alpha]

AN2 Therapeutics, Inc.  (ANTX) 
US:NYSE Investor Relations: ir.antheminc.com
PDF The financing involves selling ~8.25M shares at $2.85 per share, plus pre-funded warrants for up to 5.79M shares at $2.84999 each. The proceeds are expected to fund R [Read more]